MedX Health Corp. engages in the development, manufacture, and sale of medical device and software. The company is headquartered in Mississauga, Ontario. The company went IPO on 2008-02-12. The company develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. The company focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
Follow-Up Questions
What is the price performance of MDXHF stock?
The current price of MDXHF is $0.01, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Medx Health Corp?
Medx Health Corp belongs to Health Care industry and the sector is Health Care
What is Medx Health Corp market cap?
Medx Health Corp's current market cap is $3.0M
Is Medx Health Corp a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Medx Health Corp, including 3 strong buy, 5 buy, 1 hold, 0 sell, and 3 strong sell
